Gary E Raskob

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Placebo Controlled

Top Venues

Journal of the American Heart Association

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Alex C Spyropoulos, Gary E Raskob, Alexander T Cohen, Walter Ageno, Jeffrey I Weitz, Theodore E Spiro, Wentao Lu, Concetta Lipardi, Gregory W Albers, C Gregory Elliott, Jonathan L Halperin, William R Hiatt, Gregory Maynard, Phillippe Gabriel Steg, Chiara Sugarmann, Elliot S Barnathan
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Circulation 145 (19) (2022)
Gary E Raskob, Aaron M Wendelboe, Janis E Campbell, Lance Ford, Kai Ding, Dale W Bratzler, Micah McCumber, Alys Adamski, Karon Abe, Michele G Beckman, Nimia L Reyes, Lisa C Richardson
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Gary E Raskob, Walter Ageno, Gregory W Albers, C Gregory Elliott, Jonathan L Halperin, Gregory Maynard, Phillippe Gabriel Steg, Jeffrey I Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S Barnathan, Alex C Spyropoulos
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness. Journal of the American Heart Association 11 (20) (2022)
Gary E Raskob, Alex C Spyropoulos, Theodore E Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh, Elliot S Barnathan
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER. Journal of the American Heart Association 10 (22) (2021)